Our study showed that EMCN can promote the progression of CRC, providing a theoretical basis for improving the regulatory mechanism of CRC progression and providing experimental data for screening CRC metastasis markers and therapeutic targets. The gene discussed is EMCN; the disease is colorectal carcinoma.